Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fesoterodine vs Tolterodine ER in Overactive Bladder
NCT00444925Phase 3Completed
- Sponsor
- Pfizer
- Start
- Apr 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 29
01
Overview
A Phase 3 trial of fesoterodine in overactive bladder (OAB), sponsored by Pfizer. Started Apr 2007; status: completed.
02
Drugs
fesoterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00444925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00444925.